Lobeline


Also found in: Dictionary, Medical, Wikipedia.
Related to Lobeline: hydrastine

lobeline

[′lō·bə‚lēn]
(pharmacology)
C22H27NO2 A crystalline compound isolated from the herb and seeds of Indian tobacco (Labelia inflata); melting point is 130-131°C; soluble in hot alcohol, chloroform, and benzene; used in medicine as a respiratory stimulant.

Lobeline

 

an alkaloid contained in plants from the genus Lobelia; it is a respiratory stimulant. In medicine, lobeline hydrochloride is used in a solution, which is injected intravenously or intramuscularly. It is indicated for respiratory standstill or weakening of respiratory activity. Lobeline is sometimes used diagnostically to determine the circulation rate.

References in periodicals archive ?
A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse.
Respiratory responses of mature horses to intravenous lobeline bolus.
Cigarrest appears to combine lobeline sulfate with vitamins.
The effects of D-amphetamine, meprobamate and lobeline in the cigarette smoking behavior of normal human subjects.
HI RES PHOTOS: Lobeline Communications/Phil Lobel, 310-271-1551, ext.
MDR reversal potential of lobeline could be demonstrated in cells treated with doxorubicin in that lobeline can sensitize resistant tumor cells at non-toxic concentrations.
Contact Christopher Kingry or Phil Lobel at Lobeline Communications, 310-271-1551, to request copies.
We are in the process of analyzing various safe, natural plant nutriceutical that may recruit stem cells including low level (S)-nicotine Angiogenix(TM), lobeline, carbamyl, natural choline esterase inhibitors, and others.
WHERE: Bradley Center 1001 North Fourth Street Milwaukee, WI 53203-1314 414/227-0400 MEDIA CONTACT: Phil Lobel Lobeline Communications, 310/271-1551 Cellular phone on-site, 310/995-7552 email: sky1PHIL@aol.
DynaGen is developing NicErase sublingual lobeline sulfate for smoking cessation, NicCheck for immediate assessment of smoking status, and OrthoDyn polymers for bone repair.
NASDAQ:DYGN; BSE:DYG) today announced that the United States Patent and Trademark Office has issued a notice of allowance for the company's application for its proprietary transdermal delivery system for the administration of lobeline as an aid to smoking cessation.